Search for: "Novartis AG" Results 1 - 20 of 440
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Jan 2014, 9:59 pm by Patent Docs
Patent and Trademark Office for fifteen patents were untimely asserted by Novartis AG, Novartis Vaccines and Diagnostics, Inc., and Novartis Corporation ("Novartis"). [read post]
21 Dec 2014, 11:04 pm by Admin
The rejection was largely a result […] The post Novartis AG v. [read post]
1 Oct 2010, 4:06 am
The Court of Appeal roared back into action yesterday with its first patent decision of the new term: Novartis AG & Cibavision AG v. [read post]
28 Nov 2020, 8:06 am by Ronald V. Miller, Jr.
Beovu was supposed to be the big new revenue-making drug for pharmaceutical giant Novartis last year. [read post]
25 Jun 2020, 10:09 am by Astarita
The Securities and Exchange Commission today announced that Novartis AG, a global pharmaceutical and healthcare company headquartered in Basel, Switzerland, has agreed to pay over $112 million to settle charges that it violated the books and records and…Read the Full Press ReleaseHave a securities law question? [read post]
7 Apr 2008, 9:32 pm
Singer -- In April 7, 2008 press releases from Novartis AG and Alcon Inc., the companies announced that Novartis has reached an agreement with Nestlé S.A. which provides Novartis with the right to acquire majority ownership of Alcon Inc. [read post]
5 Feb 2008, 9:55 pm
By Donald Zuhn -- Last week, Swiss drug maker Novartis AG agree to supply its cancer drug Glivec ® at no cost to patients in Thailand in exchange for the Thai government's agreement not to issue a compulsory license on Novartis' patent. [read post]
6 Mar 2012, 6:17 am
Novartis, an affiliate of Swiss drug maker Novartis AG, has its headquarters in East Hanover, New Jersey. [read post]
19 Apr 2017, 9:23 pm by Patent Docs
Novartis AG), in which the PTAB stated in an institution decision that a particular prior art's "stated reasons for using mannitol in liquid pharmaceutical compositions are inapplicable to... [read post]
12 Jul 2010, 9:59 pm by Patent Docs
By Donald Zuhn -- Last week, Novartis AG and Novartis Vaccines and Diagnostics, Inc. filed a complaint against U.S. [read post]
8 Jan 2012, 8:24 pm by Lawrence B. Ebert
Certain bottles of Excedrin, NoDoz, Bufferin, and Gas-X are being recalled.BusinessWeek noted: Novartis AG said it’s voluntarily recalling some over-the-counter products in the U.S., including its Excedrin headache pills and NoDoz medication, because they may contain broken or stray tablets from other products.ANDNovartis said it was recalling all lots of bottles containing Excedrin and NoDoz with expiration dates of Dec. 20, 2014, or earlier as well as Bufferin and Gas-X… [read post]
3 Nov 2015, 4:00 am by taotiadmin
Novartis AG, a European based pharmaceutical company, agreed to settle a False Claims Act (FCA) lawsuit for $390 million, a… The post European Pharmaceutical Giant Novartis Settles False Claims Act Whistleblower Case for $390 Million appeared first on TZ Legal - Fraud Fighters. [read post]
24 Jun 2020, 8:43 pm
On June 19, 2020, Novartis Pharma AG of Switzerland; Novartis Pharmaceuticals Corp. of East Hanover, New Jersey; and Novartis Technology LLC of East Hanover, New Jersey (collectively, “Novartis”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337.The complaint alleges that Regeneron Pharmaceuticals, Inc. of Tarrytown, New York (“Regeneron”) unlawfully imports into the U.S., sells for… [read post]
13 Feb 2020, 8:16 am by Michael Simkovic
Bloomberg reports that Novartis AG, a Swiss Pharmaceutical firm with a Market Capitalization in excess of 220 billion USD and U.S. headquarters in Boston, is... [read post]
27 Oct 2012, 11:44 pm
In Medimmune Ltd v Novartis Pharmaceuticals UK Ltd and Another [2011] EWHC 1669 (Pat) (05 July 2011), Mr. [read post]
13 Nov 2015, 7:43 am by Altman & Altman
In fact, it may have been Novartis AG’s concerns about close competitor Roche that led to their deceptive – and illegal – practices. [read post]
4 Oct 2010, 4:35 pm by rreeves
  According to US prosecutors, Novartis Pharmaceuticals Corporation, which is the American subsidiary of Novartis AG of Switzerland, will have to pay criminal fines and forfeitures of $185 million, and more than $237 million to settle civil liabilities arising from its off label marketing. [read post]